Testing effectiveness (Phase 2)WithdrawnNCT02115126
What this trial is testing
Phase II Trial to Evaluate an EBV-derived Dendritic Cell Vaccine in Autologous Stem Cell Transplant
Who this might be right for
Hodgkin LymphomaNon-Hodgkin Lymphoma
David Rizzieri, MD